← Back
$JBIO All transactions

Jade Biosciences, Inc.

A

$ Value

$7.8M

Shares

855,047

Price

$9

Filed

Oct 8

Insider

Name

Fairmount Funds Management LLC

Title

CIK

0001802528

Roles

Director 10% Owner

Transaction Details

Transaction Date

2025-10-06

Code

A

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

855,047

Footnotes

The shares of Common Stock and Pre-Funded Warrants were purchased from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended. | Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II L.P. and Fairmount Healthcare Co-Invest IV L.P. The managers of Fairmount are Peter Harwin and Tomas Kiselak. Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. | The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of outstanding shares of common stock of the Issuer immediately after giving effect to such exercise.

Filing Info

Accession No.

0001104659-25-097921

Form Type

4

Issuer CIK

0001798749

Fairmount Funds Management LLC's History

Date Ticker Type Value
2026-03-31 COGT C
2026-03-31 COGT $242.6M
2026-03-31 COGT C $0
2026-03-31 ZBIO $3.0M
2026-03-23 DMRA A $0
2026-01-22 APGE $133.5M
2026-01-22 COGT $127.4M
2025-12-04 CBIO $18.2M
2025-12-04 CBIO $1.8M
2025-10-23 VRDN $10.0M

Other Insiders at JBIO (90d)

No other insider activity at this issuer in the last 90 days.